Las Vegas, NV -- (SBWIRE) -- 10/14/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Glimcher Realty Trust (NYSE:GRT), Revolution Lighting Technologies Inc (NASDAQ:RVLT), Cypress Semiconductor Corporation (NASDAQ:CY), Sarepta Therapeutics Inc (NASDAQ:SRPT)
Glimcher Realty Trust (NYSE:GRT) managed to keep its gain at 0.20% on above-normal volume of 1.77M shares. The stock settled at $10.05 after floating in a range of $9.95 to $10.06. Its latest price has reached market capitalization of $1.46 billion. Its 52-week range has been $9.62 to $13.34. Glimcher Realty Trust (GRT) is an integrated, self-administered and self-managed Maryland REIT which was formed on September 1, 1993 to continue the business of The Glimcher Company and its affiliates, of owning, leasing.
For How Long GRT will fight for Profitability? Read This Trend Analysis report
Revolution Lighting Technologies Inc (NASDAQ:RVLT) traded up on a volume of 1.76 million, higher than its standard daily volume. Shares have gained 5.97% to $4.26. Over the last twelve months, the stock has gained 576.19% and faced a worst price of $0.46. Revolution Lighting Technologies Inc. designs, manufacture, market and sells commercial grade, light emitting diode (LED) replacement light bulbs and LED-based signage, channel letter and contour lighting products.
For How Long RVLT’s Gloss will Attract Investors? Find out via this report
Cypress Semiconductor Corporation (NASDAQ:CY) settled 0.54% higher at $9.23 on below -normal volume of 1.75M shares during the last trading day. The stock has its 12-month high at $13.23 and 52-week low price was $8.70. It traded in a range of $9.11 to $9.26 during the last trading day. Cypress Semiconductor Corporation (Cypress), delivers high-performance, mixed-signal and programmable solutions.
Why Should Investors Buy CY After the Recent Fall? Just Go Here and Find Out
In the last trading session, Sarepta Therapeutics Inc (NASDAQ:SRPT) was down on low volume, trading at a volume of 1.74M versus its average daily volume of 2.33 million shares. At $46.65, the stock has attained market capitalization of 1.56 billion. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include Eteplirsen,
Why Should Investors Buy SRPT After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)